Catalyzing the Future of Medicinal Chemistry Research in India
- 10 August 2023
- journal article
- editorial
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 66 (16) , 10868-10877
Abstract
The present publication provides a comprehensive look at more than a decade (2010 to midyear of 2023) of medicinal chemistry research in India, focusing on contributions to medicinal chemistry and drug discovery from both Indian academia and industries. The work provides an overview of cutting-edge medicinal chemistry research along with the organic-transformation-based chemical research scenarios in India in the past decade. It also distinguishes areas of research as well as contributions from different federal research institutes, state universities, central universities, and private universities by their geographical locations around India. The paper takes broader stock of the situation by comparing the articles published in the two internationally acclaimed journals in the field, viz. Journal of Medicinal Chemistry and Organic Letters, which highlights the current research trends as well as the thrust needed at the grass-roots level to boost medicinal chemistry and drug discovery research in India. Finally, we believe that this discussion may create a pathway for policymakers and funding agencies to focus their efforts to motivate lesser inclined institutions as well as provide incentives to the institutions primarily involved in medicinal chemistry research, as they already have built capacity for such research.Keywords
Funding Information
- Council of Scientific and Industrial Research, India (HCP 41)
This publication has 24 references indexed in Scilit:
- NanoCrySP technology for generation of drug nanocrystals: translational aspects and business potentialDrug Delivery and Translational Research, 2016
- Chemistry: Chemical con artists foil drug discoveryNature, 2014
- Mahanine, A DNA Minor Groove Binding Agent Exerts Cellular Cytotoxicity with Involvement of C-7-OH and −NH Functional GroupsJournal of Medicinal Chemistry, 2013
- Balaglitazone: A Second Generation Peroxisome Proliferator-Activated Receptor (PPAR) Gamma (γ) AgonistMini-Reviews in Medicinal Chemistry, 2012
- Bioenhancers from mother nature and their applicability in modern medicineInternational Journal of Applied & Basic Medical Research, 2011
- The importance of new companies for drug discovery: origins of a decade of new drugsNature Reviews Drug Discovery, 2010
- Ragaglitazar: a novel PPARα & PPARγ agonist with potent lipid‐lowering and insulin‐sensitizing efficacy in animal modelsBritish Journal of Pharmacology, 2003
- Centchroman, a selective estrogen receptor modulator, as a contraceptive and for the management of hormone‐related clinical disordersMedicinal Research Reviews, 2001
- Actions of the muscle relaxant chandonium iodide on guinea-pig ileum and vas deferens preparationsJournal of Pharmacy and Pharmacology, 1976
- Neuromuscular and other blocking actions of a new series of mono and bisquaternary aza steroidsJournal of Pharmacy and Pharmacology, 1974